SCHEMBL10503543

SCHEMBL10503543

COc1ccc2[se]n(-c3ccccc3)c(=S)c2c1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 3/20 0.50
▸ TXNRD1 Q16881 1/20 0.48
▸ TXNRD3 Q86VQ6 1/20 0.48
▸ TXNRD2 Q9NNW7 1/20 0.48
▸ KDM4E B2RXH2 3/20 0.42
▸ MAPT P10636 4/20 0.41
▸ HTT P42858 4/20 0.41
▸ KMT2A Q03164 4/20 0.41
▸ ALDH1A1 P00352 4/20 0.41
▸ HPGD P15428 4/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ QSOX1 O00391 1/20 0.41
▸ RGS12 O14924 1/20 0.41
▸ PMM2 O15305 1/20 0.41
▸ PLIN1 O60240 1/20 0.41
▸ GMNN O75496 1/20 0.41
▸ BBOX1 O75936 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10501830 0.90 METAP2 (0.48) METAP2TXNRD1TXNRD3TXNRD2KDM4E
SCHEMBL10501657 0.84 METAP2 (0.71) METAP2TXNRD1TXNRD3TXNRD2KDM4E
SCHEMBL10501336 0.82 METAP2 (0.50) METAP2KDM4EMAPTHTTKMT2A
SCHEMBL10502111 0.82 METAP2 (0.68) METAP2KDM4EMAPTHTTKMT2A
SCHEMBL10746448 0.80 TXNRD1 (0.43) METAP2TXNRD1TXNRD3TXNRD2KDM4E
SCHEMBL10501980 0.80 METAP2 (0.41) METAP2TXNRD1TXNRD3TXNRD2KDM4E
SCHEMBL10502310 0.79 METAP2 (0.52) METAP2KDM4EMAPTHTTKMT2A
SCHEMBL10502151 0.77 METAP2 (0.44) METAP2KDM4EMAPTHTTKMT2A
SCHEMBL10501293 0.77 METAP2 (0.69) METAP2TXNRD1TXNRD3TXNRD2KDM4E
SCHEMBL10501589 0.76 METAP2 (0.61) METAP2KDM4EMAPTHTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0154851-B1 BENZISOSELENAZOLETHIONES,PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PRODUCTS CONTAINING THESE COMPOUNDS A. Nattermann & Cie. GmbH (DE) 1989-08-02 — — EP disclosed
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
EP-0154851-A1 Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds A. Nattermann & Cie. GmbH (DE) 1985-09-18 — — EP disclosed
Send feedback